6533b82afe1ef96bd128b6cb

RESEARCH PRODUCT

Identificación de oportunidades de mejora del tratamiento de la hepatitis C

C. Pérez-peiróJ.f. Márquez-peiróN.v. Jiménez-torresJ. Carmena-carmena

subject

Pharmacologymedicine.medical_specialtybusiness.industryPublic healthRibavirinMEDLINEAlpha interferonPeginterferon-alfaHepatitis Cmedicine.diseaseSurgerychemistry.chemical_compoundPharmaceutical carechemistryInternal medicinemedicineAdverse effectbusiness

description

® . Summary Objective: Hepatitis C represents a public health concern with more than 170 million carriers. The goal of this study was to identify improvement opportunities in the management of hepati- tis C, and the pharmaceutical actions performed for the preven- tion and solution of medication-related problems in patients seen at the Pharmaceutical Care Outpatient Unit.

https://doi.org/10.1016/s1130-6343(06)73966-6